A large quasi-experimental study in Wales shows that eligibility for shingles vaccination is linked to fewer new mild ...

Adults older than 50 who received the shingles vaccination experienced a decreased risk in heart disease, dementia and death, according to Ali Dehghani, DO, of Case Western Reserve University during a ...

ATLANTA -- Having herpes zoster (shingles) boosted the risk of major adverse cardiovascular events (MACE), but shingles vaccination reduced some risks for older adults, analyses presented at the ...

Dementia before age 80 is potentially preventable through early intervention on common vascular risk factors, according to research led by the Johns Hopkins Bloomberg School of Public Health. Findings ...

Novo ran two trials: evoke, which assessed Rybelsus in patients with early Alzheimer’s disease, and evoke+, which was expected to enroll about 20% of patients with vascular dementia as well as people ...

Higher LIBRA2 lifestyle scores are associated with an increased risk for dementia, particularly vascular and mixed types, but show no significant link to stroke.

The shingles vaccine can significantly reduce the chance of developing vascular dementia, while also lowering the risk of blood clots, heart attacks and death in people ages 50 and older, according to ...

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a person's stage of dementia based on neurovascular and metabolic changes. They ...

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a person's stage of dementia based on neurovascular and metabolic changes. They ...

Vascular dementia is the second leading cause of dementia. This disease co-occurs with Alzheimer’s disease in the leading cause of dementia, termed “mixed dementia.” There is no drug therapy that ...

There are several risk factors for dementia, including type 2 diabetes and obesity. A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 ...